As depicted by the results, LANCL1-AS1 displayed a significantly higher level in Lv-LANCL1-AS1-treated group than that in the control group, confirming the successful overexpression of LNACL1-AS1 in the tumor xenograft mouse model (Figure 6e). The gene discussed is LANCL1; the disease is neoplasm.